Basic information
- Standard SMILES
c1ccc(N2CCNCC2)cc1- InChIKey
YZTJYBJCZXZGCT-UHFFFAOYSA-N- Molecular formula
- C10H14N2
- Average molar mass
- 162.23 g/mol
- Monoisotopic mass
- 162.11569846
Names & identifiers
- Preferred name
- 1-Phenylpiperazine
- IUPAC
- 1-phenylpiperazine
- English name
- 1-Phenylpiperazine dihydrochloride
- Molecular formula
- C10H16Cl2N2
- Molecular weight
- 235.15
Names & synonyms
Show more names
Database identifiers
- CAS
4004-95-9、92-54-6- PubChem CID
- 7096
- DTXSID
DTXSID8057855- ChEMBL
CHEMBL9434- UNII
- J9225CBI7D
- EC Number
- 202-165-6
- Nikkaji
- J35.451A
Properties
Computed structural properties
- XLogP
- 1.1
- Topological polar surface area
- 15.3 Ų
- Hydrogen bond donors
- 1
- Hydrogen bond acceptors
- 2
- Rotatable bonds
- 1
- Heavy atoms
- 12
- Formal charge
- 0
- Complexity
- 124
Experimental & physicochemical properties
Physicochemical properties
- Melting point
- 221 · 221-223°C
- storage temp.
- Hygroscopic, Refrigerator, Under Inert Atmosphere
- solubility
- DMSO (Slightly), Methanol (Slightly), Water (Slightly)
- form
- Solid
- color
- White to Off-White
- Stability
- Hygroscopic
- FDA UNII
- 8 Y494LR4W · T8Y494LR4W
- Symbol(GHS)
- 7 · GHS07
- Signal word
- Warning
- Hazard statements
- 335 · H335-H319-H315
- Precautionary statements
- 264 · P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362
Safety & regulation
GHS classification
GHS Classification
Danger
H301 (96.9%): Toxic if swallowed [Danger Acute toxicity, oral];H310 (36.9%): Fatal in contact with skin [Danger Acute toxicity, dermal];H311 (61.5%): Toxic in contact with skin [Danger Acute toxicity, dermal];H314 (98.5%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation]
P260, P262, P264, P270, P280, P301+P316, P301+P330+P331, P302+P352, P302+P361+P354, P304+P340, P305+P354+P338, P316, P321, P330, P361+P364, P363, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 65 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Hazard information
Regulatory Information
Status: Active Update: 09-04-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/21606
Piperazine, 1-phenyl-, dihydrochloride: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Phenylpiperazine: Does not have an individual approval but may be used under an appropriate group standard
Regulatory information
Regulatory Information
Status: Active Update: 09-04-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/21606
Piperazine, 1-phenyl-, dihydrochloride: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Phenylpiperazine: Does not have an individual approval but may be used under an appropriate group standard
Safety data
- Signal word
- Warning
- Symbol(GHS)
- GHS07
- Hazard statements
- H335-H319-H315
- Precautionary statements
- P264-P280-P305+P351+P338-P337+P313P-P264-P280-P302+P352-P321-P332+P313-P362
Chemistry & industry
Pharmacology
MeSH Pharmacological Classification
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma.
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).
Uses & manufacturing
Applications
Uses1-Phenylpiperazine was tested for its activity as a topical glaucoma agent.
Suppliers7 total
Related reactions
Linked notes
Loading…